This test detects variations in the 9p21 gene. It identifies individuals who may be at an increased risk of premature CVD. This identification allows for risk reclassification and more aggressive management of modifiable risk factors. Please be advised that Boston Heart Diagnostics policy states that practitioners are unable to order labs on themselves or their immediate family members.